The combination of two vaccines that has previously failed to produce a response on their own has cut the risk of becoming infected with HIV by more than 31 per cent.
A research group supported by the National Institutes of Health (NIH) has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance.
Researchers at Harvard Medical School have identified a gene in Asian monkeys that may have evolved as a defense against lentiviruses, the group of viruses that includes HIV. The study, published February 29 in the open-access journal PLoS Pathogens, ...
